Drugs / LH-8
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT03240627 | Feb 2018 → Mar 2022 | alopecia areata | Legacy Healthcare SA | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LH-8 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03240627 ↗ |
| Route | Topical | “LH-8 cutaneous solution (0.126 mL per spray) applied to the whole scalp” NCT03240627 ↗ |